These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12115623)

  • 1. Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice.
    Feili-Hariri M; Falkner DH; Morel PA
    Eur J Immunol; 2002 Jul; 32(7):2021-30. PubMed ID: 12115623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice.
    Morin J; Faideau B; Gagnerault MC; Lepault F; Boitard C; Boudaly S
    Clin Exp Immunol; 2003 Dec; 134(3):388-95. PubMed ID: 14632742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of NOD mice with bone marrow-derived dendritic cells.
    Feili-Hariri M; Dong X; Alber SM; Watkins SC; Salter RD; Morel PA
    Diabetes; 1999 Dec; 48(12):2300-8. PubMed ID: 10580417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
    Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
    J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells.
    Kared H; Masson A; Adle-Biassette H; Bach JF; Chatenoud L; Zavala F
    Diabetes; 2005 Jan; 54(1):78-84. PubMed ID: 15616013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes.
    Turner MS; Isse K; Fischer DK; Turnquist HR; Morel PA
    Diabetologia; 2014 Jul; 57(7):1428-36. PubMed ID: 24737163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
    J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune tolerance induced by adoptive transfer of dendritic cells in an insulin-dependent diabetes mellitus murine model.
    Zhang CL; Zou XL; Peng JB; Xiang M
    Acta Pharmacol Sin; 2007 Jan; 28(1):98-104. PubMed ID: 17184588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal calf serum-primed dendritic cells induce a strong anti-fetal calf serum immune response and diabetes protection in the non-obese diabetic mouse.
    Kadri N; Potiron N; Ouary M; Jegou D; Gouin E; Bach JM; Lieubeau B
    Immunol Lett; 2007 Feb; 108(2):129-36. PubMed ID: 17196260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
    Trembleau S; Penna G; Gregori S; Gately MK; Adorini L
    Eur J Immunol; 1997 Sep; 27(9):2330-9. PubMed ID: 9341777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice.
    Creusot RJ; Yaghoubi SS; Kodama K; Dang DN; Dang VH; Breckpot K; Thielemans K; Gambhir SS; Fathman CG
    Clin Immunol; 2008 May; 127(2):176-87. PubMed ID: 18337172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice.
    Boudaly S; Morin J; Berthier R; Marche P; Boitard C
    Eur Cytokine Netw; 2002; 13(1):29-37. PubMed ID: 11956018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis.
    Vasu C; Dogan RN; Holterman MJ; Prabhakar BS
    J Immunol; 2003 Jun; 170(11):5511-22. PubMed ID: 12759428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice.
    Tominaga Y; Nagata M; Yasuda H; Okamoto N; Arisawa K; Moriyama H; Miki M; Yokono K; Kasuga M
    Clin Immunol Immunopathol; 1998 Feb; 86(2):209-18. PubMed ID: 9473384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte/macrophage colony-stimulating factor and interleukin-4-induced dendritic cells.
    Hikino H; Kasono K; Kanzaki M; Kai T; Konishi F; Kawakami M
    Anticancer Res; 2004; 24(3a):1609-15. PubMed ID: 15274330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenic dendritic cells from the non-obese diabetic mouse induce a prolonged proliferation of syngeneic T cells. A role for an impaired apoptosis of NOD T cells?
    Radosevic K; Casteels KM; Mathieu C; Van Ewijk W; Drexhage HA; Leenen PJ
    J Autoimmun; 1999 Dec; 13(4):373-82. PubMed ID: 10585753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A murine interleukin-4-Ig fusion protein regulates the expression of Th1- and Th2-specific cytokines in the pancreas of NOD mice.
    Walz M; Overbergh L; Mathieu C; Kolb H; Martin S
    Horm Metab Res; 2002 Oct; 34(10):561-9. PubMed ID: 12439784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-dendritic cell unbalance in the non-obese diabetic mice.
    Morin J; Chimènes A; Boitard C; Berthier R; Boudaly S
    Cell Immunol; 2003 May; 223(1):13-25. PubMed ID: 12914754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.